Announce Date | 05/08/2024 |
EPS Normalized Actual | $-0.08 In Line |
EPS GAAP Actual | $-0.08 In Line |
Revenue Actual | $0.017522B |
Revenue Surprise | Beat by $17.522M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $-0.065 |
EPS GAAP Estimate | $-0.065 |
Revenue Estimate | $0.015B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | -0.57 | -13.48 | -0.57 | -0.57 | 1 |
Dec 2024 | 0.13 | 59.12 | 0.09 | 0.15 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.25 | -0.25 | 0.017522B | 0.83% | 17.52M |
FQ4 2021 (Dec 2021) | -0.46 | -0.46 | 0.014144B | 9.29% | 14.14M |
FQ3 2021 (Sep 2021) | -0.3 | -0.3 | 0.015455B | 15.82% | 15.46M |
FQ2 2021 (Jun 2021) | -0.26 | -0.26 | 0.017297B | 33.83% | 17.3M |
FQ1 2021 (Mar 2021) | 0.02 | 0.02 | 0.017377B | 35.45% | 17.38M |
FQ4 2020 (Dec 2020) | -0.11 | -0.11 | 0.01283B | -1.53% | 12.83M |
FQ3 2020 (Sep 2020) | -0.03 | -0.03 | 0.01301B | -1.01% | 13.01M |
FQ2 2020 (Jun 2020) | -0.08 | -0.08 | 0.011446B | -26.35% | 11.45M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
-0.065
Consensus Revenue Estimates
0.015B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.13 | -- | 0.12892 | 0.13108 | 1 |
FQ3 2025 (Jul 2025) | 0.04 | -- | 0.03966667 | 0.04033333 | 1 |
FQ2 2025 (Jun 2025) | 0.05 | -- | 0.04947399 | 0.05052601 | 1 |
FQ1 2025 (Mar 2025) | 0 | -- | 0 | 0 | 1 |
FQ4 2024 (Oct 2024) | -0.045 | -- | -0.045375 | -0.0225 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ3 2025 (Jul 2025) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ2 2025 (Jun 2025) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ1 2025 (Mar 2025) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ4 2024 (Oct 2024) | 0.02B | -- | 0.02B | 0.02B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.25 | -0.25 | 100% | |
FQ4 2021 (Dec 2021) | -0.46 | -0.46 | 100% | |
FQ3 2021 (Sep 2021) | -0.3 | -0.3 | 100% | |
FQ2 2021 (Jun 2021) | -0.26 | -0.26 | 100% | |
FQ1 2021 (Mar 2021) | 0.02 | 0.02 | 100% | |
FQ4 2020 (Dec 2020) | -0.11 | -0.11 | 100% | |
FQ3 2020 (Sep 2020) | -0.03 | -0.03 | 100% | |
FQ2 2020 (Jun 2020) | -0.08 | -0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.02B | $17.52M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.01B | $14.14M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.02B | $15.46M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.02B | $17.3M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.02B | $17.38M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.01B | $12.83M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.01B | $13.01M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.01B | $11.45M | 100% |